NEXALIN TECHNOLOGY INC (NXL) Stock Overview
USA - NASDAQ:NXL - US65345B2016 - Common Stock
NXL Key Statistics, Chart & Performance
The current stock price of NXL is 1.44 USD. In the past month the price increased by 53.85%. In the past year, price decreased by -37.12%.
NXL Latest News, Press Relases and Analysis
NXL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.42 | 220.78B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.47 | 195.91B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.27 | 149.82B | ||
| SYK | STRYKER CORP | 29.71 | 145.96B | ||
| MDT | MEDTRONIC PLC | 16.94 | 120.15B | ||
| BDX | BECTON DICKINSON AND CO | 13.02 | 53.26B | ||
| IDXX | IDEXX LABORATORIES INC | 53.36 | 51.27B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.61 | 44.68B | ||
| RMD | RESMED INC | 27.17 | 37.87B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.77 | 35.68B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.26 | 27.76B | ||
| DXCM | DEXCOM INC | 41.37 | 27.58B |
Related stock screener links
About NXL
Company Profile
Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Houston, Texas and currently employs 6 full-time employees. The company went IPO on 2022-09-16. The firm has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety, depression and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. The company has also designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.
Company Info
NEXALIN TECHNOLOGY INC
1776 Yorktown, Suite 550
Houston TEXAS US
Employees: 6
Phone: 18322600222
NEXALIN TECHNOLOGY INC / NXL FAQ
Can you describe the business of NEXALIN TECHNOLOGY INC?
Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Houston, Texas and currently employs 6 full-time employees. The company went IPO on 2022-09-16. The firm has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety, depression and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. The company has also designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. Its products are non-invasive and undetectable to the human body.
What is the stock price of NEXALIN TECHNOLOGY INC today?
The current stock price of NXL is 1.44 USD. The price decreased by -2.7% in the last trading session.
Does NEXALIN TECHNOLOGY INC pay dividends?
NXL does not pay a dividend.
What is the ChartMill technical and fundamental rating of NXL stock?
NXL has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for NEXALIN TECHNOLOGY INC?
NEXALIN TECHNOLOGY INC (NXL) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How many employees does NEXALIN TECHNOLOGY INC have?
NEXALIN TECHNOLOGY INC (NXL) currently has 6 employees.
What is NEXALIN TECHNOLOGY INC worth?
NEXALIN TECHNOLOGY INC (NXL) has a market capitalization of 26.19M USD. This makes NXL a Nano Cap stock.
NXL Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to NXL. When comparing the yearly performance of all stocks, NXL is a bad performer in the overall market: 77.53% of all stocks are doing better.
NXL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NXL. While NXL has a great health rating, there are worries on its profitability.
NXL Financial Highlights
Over the last trailing twelve months NXL reported a non-GAAP Earnings per Share(EPS) of -0.76. The EPS decreased by -2.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -134.84% | ||
| ROE | -148.42% | ||
| Debt/Equity | 0 |
NXL Forecast & Estimates
5 analysts have analysed NXL and the average price target is 4.08 USD. This implies a price increase of 183.33% is expected in the next year compared to the current price of 1.44.
For the next year, analysts expect an EPS growth of 19.67% and a revenue growth 34.3% for NXL